Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2026-05-15
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 7 call positions ($89.0m notional), 9 put positions ($289.9m notional) – listed below, not included above.
Holdings, Q1 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| UNITED THERAPEUTICS CORP DEL UTHR | $156.7m10.33% | Added +11.7k |
| ABIVAX SA ABVX | $104.0m6.86% | Added +276.6k |
| GSK PLC GSK | $98.5m6.49% | Reduced -894.5k |
| VERA THERAPEUTICS INC VERA | $87.4m5.76% | Reduced -899.0k |
| NATERA INC NTRA | $76.9m5.07% | Added +50.2k |
| SYNDAX PHARMACEUTICALS INC SNDX | $67.4m4.44% | Reduced -428.8k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $56.7m3.74% | Added +353.3k |
| VAXCYTE INC PCVX | $53.7m3.54% | Reduced -273.5k |
| BROOKDALE SR LIVING INC BKD | $48.8m3.22% | Added +3.2m |
| IONIS PHARMACEUTICALS INC IONS | $47.5m3.13% | Added +93.9k |
| HCA HEALTHCARE INC HCA | $37.5m2.47% | Reduced -16.6k |
| WELLTOWER INC WELL | $35.8m2.36% | New |
| HEALTHPEAK PROPERTIES INC DOC | $32.5m2.14% | New |
| INSULET CORP PODD | $30.1m1.99% | Added +68.8k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $28.9m1.91% | Added +46.9k |
| GERON CORP GERN | $28.1m1.85% | Added +1.2m |
| OMEGA HEALTHCARE INVS INC OHI | $25.7m1.69% | New |
| LIQUIDIA CORPORATION LQDA | $25.6m1.68% | Added +167.9k |
| COMMUNITY HEALTH SYS INC NEW CYH | $25.5m1.68% | Added +733.5k |
| AVANTOR INC AVTR | $23.3m1.54% | Reduced -202.4k |
| QIAGEN NV QGEN | $21.8m1.44% | New |
| ENCOMPASS HEALTH CORP EHC | $18.8m1.24% | Added +87.2k |
| ELI LILLY & CO LLY | $17.5m1.15% | Added +8.4k |
| TRAVERE THERAPEUTICS INC TVTX | $16.1m1.06% | Reduced -632.4k |
| CYTOMX THERAPEUTICS INC CTMX | $15.0m0.99% | Added +681.4k |
| REPLIGEN CORP RGEN | $14.2m0.94% | New |
| BETA BIONICS INC BBNX | $14.2m0.93% | Added +736.6k |
| VIRIDIAN THERAPEUTICS INC VRDN | $14.0m0.92% | Reduced -1.1m |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $13.6m0.90% | Added +141.9k |
| ARDELYX INC ARDX | $13.4m0.88% | Added +514.3k |
| LTC PPTYS INC LTC | $11.9m0.79% | New |
| BIOMARIN PHARMACEUTICAL INC BMRN | $11.7m0.77% | Added +114.0k |
| CHEMED CORP NEW CHE | $11.7m0.77% | New |
| PHARVARIS N V PHVS | $11.5m0.76% | Reduced -32.2k |
| PENNANT GROUP INC PNTG | $9.5m0.63% | Added +18.2k |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $9.1m0.60% | Reduced -135.1k |
| PALISADE BIO INC PALI | $8.7m0.58% | Reduced -404.0k |
| MODERNA INC MRNA | $8.1m0.53% | Reduced -108.1k |
| VIKING THERAPEUTICS INC VKTX | $7.8m0.51% | New |
| ICON PLC ICLR | $7.6m0.50% | Reduced -27.1k |
| XENON PHARMACEUTICALS INC XENE | $7.5m0.50% | Reduced -101.8k |
| REVVITY INC RVTY | $7.4m0.49% | Reduced -77.9k |
| AGIOS PHARMACEUTICALS INC AGIO | $6.8m0.45% | New |
| STRUCTURE THERAPEUTICS INC GPCR | $6.7m0.44% | Added +10.5k |
| BIO-TECHNE CORP TECH | $6.6m0.43% | Reduced -251.5k |
| GLAUKOS CORP GKOS | $6.5m0.43% | Reduced -87.3k |
| TENET HEALTHCARE CORP THC | $5.6m0.37% | New |
| MADRIGAL PHARMACEUTICALS INC MDGL | $5.2m0.34% | New |
| INTUITIVE SURGICAL INC ISRG | $5.1m0.34% | Reduced -6.9k |
| ESPERION THERAPEUTICS INC NE ESPR | $4.8m0.31% | Reduced -2.1m |
| MOLINA HEALTHCARE INC MOH | $4.4m0.29% | Reduced -12.7k |
| HEALTHEQUITY INC HQY | $4.3m0.28% | Reduced -134.1k |
| BRUKER CORP BRKR | $4.2m0.28% | Reduced -666.8k |
| DAY ONE BIOPHARMACEUTICALS I COM | $3.9m0.26% | New |
| COMPASS PATHWAYS PLC CMPS | $3.7m0.25% | New |
| CENTENE CORP DEL CNC | $3.7m0.24% | Reduced -212.4k |
| GRACE THERAPEUTICS INC GRCE | $3.5m0.23% | New |
| ENGENE HOLDINGS INC COM | $3.5m0.23% | Added +54.7k |
| ENHABIT INC EHAB | $3.2m0.21% | Added +8.9k |
| DEFINIUM THERAPEUTICS INC DFTX | $3.0m0.20% | New |
| EQUILLIUM INC EQ | $3.0m0.20% | New |
| ENSIGN GROUP INC ENSG | $3.0m0.20% | New |
| INVIVYD INC IVVD | $3.0m0.20% | Added +136.2k |
| PMV PHARMACEUTICALS INC PMVP | $2.9m0.19% | New |
| ALECTOR INC ALEC | $2.9m0.19% | Added +344.9k |
| ALTO NEUROSCIENCE INC ANRO | $2.8m0.19% | New |
| RELAY THERAPEUTICS INC RLAY | $2.7m0.18% | Reduced -218.4k |
| REPLIMUNE GROUP INC REPL | $2.6m0.17% | New |
| LB PHARMACEUTICALS INC LBRX | $2.5m0.16% | New |
| LIPOCINE INC NEW LPCN | $2.4m0.16% | New |
| VIR BIOTECHNOLOGY INC VIR | $2.2m0.15% | New |
| ANTERIS TECHNOLOGIES GLOBAL AVR | $2.2m0.15% | Reduced -98.8k |
| AMARIN CORP PLC AMRN | $2.1m0.14% | Reduced -24.5k |
| SAVARA INC SVRA | $2.1m0.14% | Added +214.1k |
| RELMADA THERAPEUTICS INC RLMD | $1.9m0.13% | New |
| CONTINEUM THERAPEUTICS INC CTNM | $1.9m0.13% | Added +8.9k |
| SUTRO BIOPHARMA INC STRO | $1.8m0.12% | Reduced -120.4k |
| INOVIO PHARMACEUTICALS INC INO | $1.8m0.12% | New |
| SURROZEN INC SRZN | $1.7m0.11% | Reduced -36.7k |
| INFLARX NV IFRX | $1.6m0.10% | Added +1.3k |
| KARYOPHARM THERAPEUTICS INC KPTI | $1.5m0.10% | New |
| ANAPTYSBIO INC ANAB | $1.5m0.10% | Reduced -93.8k |
| NOVOCURE LTD NVCR | $1.5m0.10% | Added +13.9k |
| BIOVENTUS INC BVS | $1.5m0.10% | Reduced -312.1k |
| AGILON HEALTH INC AGL | $1.4m0.09% | New |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $1.3m0.09% | Reduced -254.6k |
| EVOMMUNE INC EVMN | $1.3m0.08% | New |
| IMMUNOCORE HLDGS PLC IMCR | $1.2m0.08% | New |
| ASSEMBLY BIOSCIENCES INC ASMB | $1.1m0.07% | Reduced -118.8k |
| PLIANT THERAPEUTICS INC PLRX | $1.1m0.07% | Added +49.4k |
| ARS PHARMACEUTICALS INC SPRY | $1.1m0.07% | Reduced -115.4k |
| AADI BIOSCIENCE INC WHWK | $1.1m0.07% | Added +46.5k |
| TYRA BIOSCIENCES INC TYRA | $1.0m0.07% | Reduced -251.5k |
| PASSAGE BIO INC PASG | $1.0m0.07% | Added +5.4k |
| DIVERSIFIED HEALTHCARE TR DHC | $1.0m0.07% | New |
| INMODE LTD INMD | $926.7k0.06% | Added +5.8k |
| SONIDA SENIOR LIVING INC SNDA | $917.1k0.06% | New |
| BICYCLE THERAPEUTICS PLC BCYC | $884.9k0.06% | Added +11.8k |
| EDITAS MEDICINE INC EDIT | $718.6k0.05% | Unchanged |
| SS INNOVATIONS INTERNATIONAL SSII | $550.8k0.04% | Added +34.8k |
Sold out since Q4 2025
| Security | Value then |
|---|---|
| DANAHER CORPORATION DHR | $42.6m186.3k shares |
| EXACT SCIENCES CORP EXAS | $24.5m241.7k shares |
| CIDARA THERAPEUTICS INC CDTX | $21.8m98.7k shares |
| TEVA PHARMACEUTICAL INDS LTD | $20.6m660.2k shares |
| UNITEDHEALTH GROUP INC UNH | $20.1m60.9k shares |
| BIOGEN INC BIIB | $13.7m77.9k shares |
| SELECT MED HLDGS CORP SEM | $13.5m906.1k shares |
| CG ONCOLOGY INC CGON | $12.8m308.5k shares |
| BRISTOL-MYERS SQUIBB CO BMY | $12.7m235.3k shares |
| ELEVANCE HEALTH INC ELV | $10.6m30.2k shares |
| MANNKIND CORP MNKD | $10.5m1.9m shares |
| ASCENDIS PHARMA A/S | $10.3m48.2k shares |
| ILLUMINA INC ILMN | $10.1m76.7k shares |
| DYNAVAX TECHNOLOGIES CORP DVAX | $9.3m606.0k shares |
| EDGEWISE THERAPEUTICS INC EWTX | $8.4m337.3k shares |
| CATALYST PHARMACEUTICALS INC CPRX | $8.4m358.2k shares |
| HUMANA INC HUM | $8.3m32.5k shares |
| REGENERON PHARMACEUTICALS REGN | $7.8m10.1k shares |
| CVS HEALTH CORP CVS | $5.1m63.7k shares |
| ACADIA PHARMACEUTICALS INC ACAD | $4.7m176.6k shares |
| PROTAGONIST THERAPEUTICS INC PTGX | $4.6m53.0k shares |
| ZENAS BIOPHARMA INC ZBIO | $4.4m121.0k shares |
| NATIONAL HEALTHCARE CORP NHC | $3.9m28.6k shares |
| FORTREA HLDGS INC FTRE | $3.9m224.1k shares |
| MARAVAI LIFESCIENCES HLDGS I MRVI | $2.3m718.6k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| INVESCO QQQ TR QQQ · Put | $137.8m238.7k shares | Added |
| SPDR S&P 500 ETF TR SPY · Put | $69.6m107.0k shares | Added |
| VERTEX PHARMACEUTICALS INC VRTX · Call | $40.2m90.0k shares | New |
| ISHARES TR TLT · Put | $37.2m428.8k shares | Added |
| QIAGEN NV QGEN · Call | $19.1m476.3k shares | New |
| INSMED INC INSM · Call | $15.4m94.0k shares | New |
| ISHARES TR HYG · Put | $14.3m180.0k shares | New |
| UNITEDHEALTH GROUP INC UNH · Call | $10.8m40.0k shares | New |
| ISHARES TR IWM · Put | $9.9m40.0k shares | New |
| SELECT SECTOR SPDR TR XLK · Put | $9.3m70.0k shares | New |
| PRAXIS PRECISION MEDICINES I PRAX · Put | $4.8m14.8k shares | New |
| SPDR SER TR XBI · Put | $3.8m30.0k shares | Reduced |
| UNIVERSAL HLTH SVCS INC UHS · Put | $3.3m18.2k shares | New |
| SELECT SECTOR SPDR TR XLE · Call | $3.1m50.0k shares | New |
| REPLIMUNE GROUP INC REPL · Call | $397.8k52.0k shares | New |
| KARYOPHARM THERAPEUTICS INC KPTI · Call | $132.6k23.8k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |